These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36841054)

  • 1. Effects of endogenous and exogenous N-acetyl-5-methoxy kynuramine on object recognition memory in male C3H mice.
    Iwashita H; Sano M; Chiba A
    Horm Behav; 2023 Apr; 150():105329. PubMed ID: 36841054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The melatonin metabolite N1-acetyl-5-methoxykynuramine facilitates long-term object memory in young and aging mice.
    Iwashita H; Matsumoto Y; Maruyama Y; Watanabe K; Chiba A; Hattori A
    J Pineal Res; 2021 Jan; 70(1):e12703. PubMed ID: 33125735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
    Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
    J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin.
    León J; Escames G; Rodríguez MI; López LC; Tapias V; Entrena A; Camacho E; Carrión MD; Gallo MA; Espinosa A; Tan DX; Reiter RJ; Acuña-Castroviejo D
    J Neurochem; 2006 Sep; 98(6):2023-33. PubMed ID: 16945113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetyl-5-methoxykynuramine enhance object location and working memory performances via modulating CaMKII, ERK and CREB phosphorylation.
    Iwashita H; Sano M; Kawaguchi M; Chiba A
    Neuroreport; 2023 Mar; 34(5):299-307. PubMed ID: 36881754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
    Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
    Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
    Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
    J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK.
    Guenther AL; Schmidt SI; Laatsch H; Fotso S; Ness H; Ressmeyer AR; Poeggeler B; Hardeland R
    J Pineal Res; 2005 Oct; 39(3):251-60. PubMed ID: 16150105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N1-Acetyl-5-Methoxykynuramine (AMK) is produced in the human epidermis and shows antiproliferative effects.
    Kim TK; Lin Z; Li W; Reiter RJ; Slominski AT
    Endocrinology; 2015 May; 156(5):1630-6. PubMed ID: 25679869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products.
    Than NN; Heer C; Laatsch H; Hardeland R
    Redox Rep; 2006; 11(1):15-24. PubMed ID: 16571272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
    Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
    J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the tyrosine side-chain fragment, 4-ethylphenol.
    Nowak A; Rahman H; Heer C; Schueth A; Laatsch H; Hardeland R
    Redox Rep; 2008; 13(3):102-8. PubMed ID: 18544227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic melatonin significantly reduces Alzheimer's neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPP(swe)/PS1 mice.
    O'Neal-Moffitt G; Delic V; Bradshaw PC; Olcese J
    Mol Neurodegener; 2015 Jul; 10():27. PubMed ID: 26159703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger.
    Schaefer M; Hardeland R
    J Pineal Res; 2009 Jan; 46(1):49-52. PubMed ID: 18643875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin enhances photo-oxidation of 2',7'-dichlorodihydrofluorescein by an antioxidant reaction that renders N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
    Hevia D; Mayo JC; Tan DX; Rodriguez-Garcia A; Sainz RM
    PLoS One; 2014; 9(10):e109257. PubMed ID: 25275380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis.
    Kelly RW; Amato F; Seamark RF
    Biochem Biophys Res Commun; 1984 May; 121(1):372-9. PubMed ID: 6428407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds.
    Hardeland R
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine.
    Hardeland R; Backhaus C; Fadavi A
    J Pineal Res; 2007 Nov; 43(4):382-8. PubMed ID: 17910607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolomic perspective of melatonin metabolism in the mouse.
    Ma X; Chen C; Krausz KW; Idle JR; Gonzalez FJ
    Endocrinology; 2008 Apr; 149(4):1869-79. PubMed ID: 18187545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of melatonin and resveratrol on recognition memory and passive avoidance performance in a mouse model of Alzheimer's disease.
    Labban S; Alghamdi BS; Alshehri FS; Kurdi M
    Behav Brain Res; 2021 Mar; 402():113100. PubMed ID: 33417994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.